PARP1 and malignant colon neoplasm: In colon cancer cells, SHP2 was indicated to dephosphorylate poly (ADP-ribose) polymerase 1 (PARP-1) and thus to suppress DNA repair while promoting the cGAS-STING activation to elevate the sensitization of chemotherapy in colon cancer cells (111, 130).